THI in full swing about cardiovascular health …. Interesting video presentation….. they are likely a big part of how Mesoblast move forward with our accelerated approval pathway for Rexlemestrocel-L in patients with end-stage ischemic heart failure with reduced ejection fraction (HFrEF) and a left ventricular assist device (LVAD).
https://tv.texasheart.org/cardiolog...md-the-texas-heart-institute-a-year-in-review
THI is committed to excellence in advancing #cardiovascularhealth.
During Grand Rounds, @JRogersMD1, our President & CEO, highlighted achievements in our clinical programs, exciting research accomplishments, and many educational innovations.
Cell Therapy News/Articles, page-17769
-
- There are more pages in this discussion • 365 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
-0.005(0.54%) |
Mkt cap ! $1.050B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 92.5¢ | 91.5¢ | $1.133M | 1.233M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 151980 | 91.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.0¢ | 29989 | 2 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |